Introduction {#sec1-1}
============

Smooth and glowing complexion of the face increases the beauty of a person and also gives self-confidence. *Vyanga* is a disease, which decreases the glowing complexion of the face and affects the skin. Among many diseases concerned with cosmetic values, *Vyanga* is common disease known to us from thousands of years. Though it is considered as Kshudra Roga (minor disease), has got a major importance as a cosmetic problem in the society. It is characterized by the presence of *Niruja* (painless), *Tanu* (thin) and Shavavarna *Mandalas* (bluish-black patches) on face,\[[@ref1]\] occurs due to vitiation of *Vata*, Pitta followed by *Rakta Dosha*.\[[@ref2]\] Treating this condition has become a problem, since safe drugs are not available for long-term therapy.

In modern medical science, topical steroids have been described in the management of facial melanosis.\[[@ref3]\] However, the topical steroids are not completely free from adverse effects such as irritation, rashes.\[[@ref4]\] Apart from this, generally the topical steroids are expensive and sometimes poor patients cannot afford this treatment. Hence there is a need to search better methods of management in facial melanosis considering the above drawbacks.

Ayurveda mentions a good number of medicines for skin care. Massage with oils, application of paste of medicines etc., makes the face smooth, soft and glowing.\[[@ref5]\] In addition to this, bloodletting is also described.\[[@ref6]\]

Drugs having *Kusthaghna*, *Kandughna*, *Raktashodhaka*, *Twak Prasadaka* and *Varnyakara* properties are helpful in the management and can produce cutaneous depigmentation that remove the blackish discoloration of skin.

Considering these points, *Arjunatwak Churna* was selected for *Lepa*\[[@ref7]\] and *Panchanimba Churna* was selected for oral medication as these preparations have *Kusthaghna*, *Kandughna*, *Raktashodhaka*, *Twak Prasadaka* and *Varnyakara* properties.

Materials and Methods {#sec1-2}
=====================

Source of data {#sec2-1}
--------------

Patients, fulfilling the clinical criteria of *Vyanga* were randomly selected irrespective of their sex, religion, occupation, etc., from out-patient department and inpatient department sections of the Department of Shalakya Tantra, S.J.I.I.M Bangalore, Karnataka. The study was cleared by the Institutional Ethics Committee (vide letter no.: GAMC / IEC / Shalakya / 11.01.2000 / 11). Written consent was taken from each patient willing to participate before starting the study.

Inclusion criteria {#sec2-2}
------------------

Age group: 15-45 yearsChronicity less than 5 yearsShavavarnayukta, *Niruja Mandalas* present over the face.

Exclusion criteria {#sec2-3}
------------------

Any specific disease underlying as the cause of *Vyanga* like,

Inflammatory pigmentationMalignant melanomaAcne Vulgaris were excluded from the study.

### Investigations {#sec3-1}

Routine investigations of blood, urine and stool were carried out before treatment to rule out any systemic diseases.

### Arjuna Twak Churna and Panchanimba Churna preparation {#sec3-2}

*Arjuna Twak* Churna and *Panchanimba Churna*\[[@ref8]\] were prepared according to the standard method of preparation of Churna, in the pharmacy of GAMC Bangalore. The ingredients of *Panchanimba Churna* are depicted at [Table 1](#T1){ref-type="table"}.

###### 

Ingredients of *Panchanimba Churna*
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Grouping and treatment schedule {#sec2-4}
-------------------------------

A total of 30 patients were registered and divided in two groups, comprising 15 patients each in Group A and Group B.

### Group A {#sec3-3}

The patients under this group were treated with Lepa of *Arjunatwak Churna* along with *Madhu* for 30 min, once daily for 21 days.

### Group B {#sec3-4}

The patients under this group were treated with Lepa of *Arjunatwak Churna* along with *Madhu* for 30 min, once daily and internal medication of *Panchanimba Churna* in the dose of 4 g for three times daily with water after food for 21 days.

### Follow-up {#sec3-5}

Patients were asked to attend the OPD on alternate weeks for follow-up for a period of 90 days.

Observations and Results {#sec1-3}
========================

Maximum number of patients (56.66%) were in the age group of 26-35 years. Majority of the patients were females (90%). Most of the patients (63.33%) were from middle class. Nearly 56.67% of patients have patches on cheeks, nose and fore head. In 43.33% of patients, the color of patch was dark brown, in 33.33% it was blue-black and in 23.34% of patients it was light brown in color.

Pattern of changes in the color of *Mandalas* with the treatment in group A {#sec2-5}
---------------------------------------------------------------------------

In Group A, before treatment, in three patients the *Mandalas* were blue black colored, in eight patients the *Mandalas* were dark brown colored and in four patients the *Mandalas* were light brown colored. On 7^th^ day of observation, in three patients the color of *Mandalas* became to bluish black, in seven patients the color became to dark brown, in four patients, it was light brown and one patient attained the normal skin color. On 14^th^ day of observation, two patients had bluish black colored patches, three patients had dark brown patches, three patients had light brown colored patches and seven patients attained the normal skin color. At the end of the treatment, in two patients the patches were dark brown in color, in four patients the patches were light brown in color and nine patients attained normal skin color.

In group A, out of 15 patients, 09 patients were cured completely, which was statistically significant at the level of *P* \< 0.01. Four patients have shown marked improvement and two patients showed slight improvement. Statistically significant result was obtained in the symptom blackish/brownish patch over the face \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of therapy on chief complaint (bluish-black discoloration of skin)
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Pattern of changes in the color of *Mandalas* with the treatment in group B {#sec2-6}
---------------------------------------------------------------------------

In Group B, before treatment, in seven patients the *Mandalas* were bluish black colored, in five patients the *Mandalas* were dark brown colored and in three patients the *Mandalas* were light brown colored. On 7^th^ day of observation, in seven patients the color of *Mandalas* became bluish black, in four patients the color became dark brown, in two patients it became light brown and two patients attained the normal skin color. On 14^th^ day of observation, three patients attained bluish black colored patches, two patients had dark brown patches, two patients had light brown colored patches and eight patients attained the normal skin color. At the end of treatment, one patient had dark brown color patches. In two patients, the light brown colored patches were still persisting and 12 patients had attained normal skin color.

In group B, out of 15 patients, 12 patients had attained normal skin color, which was statistically highly significant at the level of *P* \< 0.001, also one patient had mild improvement and two patients have moderate improvement. Statistically significant result was obtained in the symptom bluish-black patch over the face \[[Table 2](#T2){ref-type="table"}\].

The images shows effect of the treatment in one of the patients of Group B \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\].

![Before treatment](AYU-35-50-g003){#F1}

![After treatment](AYU-35-50-g004){#F2}

Discussion {#sec1-4}
==========

*Vyanga* is explained as a *Kshudra Roga* in Ayurveda. While describing the etiological factors of *Vyanga*, Acharya has given special emphasis towards psychological factors like *Krodha* (anger), *Shoka* (grief) and *Shrama* (exhaustion), which are commonly found in most of the patients. In Samprapti of *Vyanga*, Acharya Charaka has mentioned that the aggravation of *Pitta* along with *Rakta* is the chief culprit for initiation of the pathology. *Vyanga* is a *Rakta Pradoshaja Vyadhi*,\[[@ref9]\] hence the very first Dosha affected is *Rakta Dhatu*. *Dosha Prakopaka Hetus* like *Krodha*, *Shoka* and *Shrama* are mainly Tama (*Manasika Dosha*), Pitta and *Vata* (*Shareerika Dosha*) dominance,\[[@ref10]\] vitiates the *Agni* (*Pitta Dosha*) which resides in *Rasa* and initiates the pathogenesis of *Vyanga*. Here *Ranjaka Pitta* is responsible for the conversion of *Rasa Dhatu* into *Rakta Dhatu* which results in the formation of normal skin color. However due to etiological factors like *Krodha* and *Shoka* mainly *Pitta* vitiation takes place which in turn affects the Jatharagni and normal functioning of *Ranjaka Pitta* i.e., *Varnotpatti*. Based on Ashraya-Ashrayee Bhavas, the derangement of *Pitta Dosha* leads to abnormality of *Rakta Dhatu*. *Shrama* and *Shoka* will lead to *Udana Vata* vitiation. Thus vitiated *Ranjaka Pitta*, *Rakta Dhatu* as well as *Udana Vata* travel in body through *Dhamanis* and get *Sthana Samshraya* in *Mukhagata Twacha* and causes vitiation of *Bhrajaka Pitta* giving rise to discoloration of the skin.

Mode of action of drug {#sec2-7}
----------------------

The mode of action of the drug under trial can be understood on the basis of inherent properties of the drug.

Rasa of *Arjunatwak* is *Kashaya Rasa*,\[[@ref11]\] *Gunas* are *Laghu*, *Ruksha*, *Veerya* is *Sheeta* and mainly having *Pitta Shamaka* and *Rakta Prasadaka* properties. With property of *Kashaya Rasa*, it will encounters *Pitta* and *Rakta Dosha*. The *Kashaya Rasa* removes the *Twak Vaivarnyata* and helps to attain the normal skin color.\[[@ref12][@ref13]\] Due to *Sheeta Veerya* it encounters the *Pitta Dosha*. *Prasadana* property of *Sheeta Veerya* also helps to purify the accumulated *Doshas* in *Vyanga*. The *Rakta Prasadaka* and *Twak Prasadaka* actions of *Arjuna* help to pacify the *Sanchita Doshas* locally. In *Panchnimba* Churna almost all drugs like *Nimba*, *Bakuchi*\[[@ref14]\] *Araghwadha*, *Haridra*, *Chakramarda*, *Bhallataka* etc., are having *Rakta Prasadaka* and *Twak Doshahara* properties. In *Panchanimba Churna* the main ingredient is *Nimba* that have *Tikta*, *Kashaya Rasa* and *Laghu*, *Snigdha* properties by which *Pitta Shamaka* action can be observed. *Aragwadha*\[[@ref15]\] *Amalaki*\[[@ref16]\] *Maricha*, *Nimba* and *Haridra*\[[@ref17]\] are having *Kusthaghna* and *Kandughna* properties by which possibly significant efficacy was observed.

Conclusion {#sec1-5}
==========

Both trial drugs showed encouraging results. *Arjuna Twak* along with *Madhu* has not shown any skin reactions, so it could be used safely. From the observations and results of this study, it can be concluded that *Arjuna Twak Lepa* along with *Panchanimba Churna* have provided better results in hyperpigmentation of the patches seen in cases of *Vyanga*.
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